查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715863

人体类器官市场（按类型、来源、技术、应用和最终用途）—2025-2030 年全球预测

Human Organoids Market by Type, Source, Technology, Application, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年人体类器官市场价值将达11.1亿美元，2025年将达12.6亿美元，复合年增长率为15.04%，到2030年将达25.8亿美元。

主要市场统计数据
基准年2024年 11.1亿美元
预计2025年 12.6亿美元
预测年份 2030 25.8亿美元
复合年增长率（%） 15.04%

人类类器官的发展和引入重新定义了生物医学研究和医疗保健创新的格局。近年来，这些复杂的三维结构由于其能够模拟人体器官的结构和功能而引起了相当大的关注。这一新兴领域为先进的疾病建模、个人化医疗方法以及对细胞发育的更细緻的理解铺平了道路。研究人员和产业领袖越来越多地投资于类器官技术，因为它为传统的体内和体外方法提供了一个有希望的替代方案。透过提供更准确、更可重复的人体生理模型，类器官有可能促进预测药物反应和毒性，简化药物发现过程，并降低与临床试验相关的风险。

当前的市场趋势反映出学术和商业性兴趣的激增，同时伴随着大量的技术创新和跨学科研究合作。随着新突破的不断出现，类器官在再生医学、肿瘤学研究和感染疾病研究领域的作用和影响可能会扩大。本摘要说明探讨了这个充满活力的市场背后的驱动力以及在这个不断变化的环境中取得成功所需的策略见解。

改变人类类器官市场

近年来，人类类器官周围的环境发生了重大变化。这一转变的标誌是快速发展的调查方法、新技术的整合以及对细胞复杂性的更深入理解，推动了下一波生物医学创新。主要促成因素包括微工程技术的进步、类器官培养可重复性的提高以及使高通量筛检更可行的自动化系统的整合。

此外，成像和数据分析方面的开创性发展提高了这些系统评估的准确性。即时监测和先进的基因编辑等新技术也有助于提高类器官模型的准确性。科技与生物学的融合不仅扩大了应用范围，从药物发现和毒性测试到个人化治疗策略，而且还使得人们能够更全面地了解疾病机制。

该领域正在迅速从单纯的学术研究转向工业应用，从而吸引了大量投资和战略伙伴关係。随着相关人员在研究机构、生技公司和製药公司之间积极合作，以及这些学科的融合，类器官技术前所未有的成长和创新即将到来。这些产业转变正在重新定义市场边界并重塑生物医学研究和临床应用的传统典范。

类器官市场的关键细分洞察

根据生物、技术和应用因素的组合，类器官市场细分描绘出一幅多面向的景象。根据类型，正在对脑类器官、心臟类器官、肠道类器官、肾臟类器官、肝臟类器官、肺类器官和胰腺类器官进行评估，每种类器官都为器官特异性功能和疾病建模提供了独特的见解。用于培养这些类器官的细胞来源增加了额外的复杂性，研究和开发主要利用成体干细胞、胚胎组织和多功能细胞。这些潜在的生物输入对于确定类器官的复製保真度和功能精度至关重要。

支持这一市场的技术进步包括 3D 生物列印、细胞培养技术、水凝胶、基于支架的技术和磁浮等创新。每一种技术都为类器官製造的整体效率和扩充性做出了独特的贡献。类器官技术的应用涵盖药物发现、感染疾病研究、神经病学研究、肿瘤学研究、个人化医疗和再生医学。这些应用不仅凸显了类器官的多功能性，也强调了重要研究领域对此模型的日益依赖。最后，类器官技术的最终用途非常广泛，包括生物技术公司、製药公司和研究实验室，这表明各个行业对它有浓厚的兴趣和投资。

整合这些细分见解将使相关人员能够有效地客製化他们的策略以针对特定的市场细分，同时推动对准确和可靠的细胞模型需求不断增长的领域的创新。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 政府对科学研究和组织工程的支持政策和资金
      • 慢性病的流行推动了对有效治疗研究的需求
      • 对个人化医疗和客製化医疗保健解决方案的需求不断增加
    • 限制因素
      • 人体类器官技术研发成本不断上升
    • 机会
      • 生技公司和创投家对类器官技术的投资不断增加
      • 创新技术进步推动人体类器官研究与开发
    • 任务
      • 确保人体类器官生产和应用的道德标准和监管地位
  • 市场区隔分析
    • 肝类器官在药理学和毒理学研究中的新兴作用
    • 针对生物技术、製药和研究机构的人体类器官创新市场細項分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 人体类器官市场（依类型）

  • 脑类器官
  • 心臟类器官
  • 肠道类器官
  • 肾臟类器官
  • 肝臟类器官
  • 肺类器官
  • 胰臟类器官

7. 人体类器官市场（依来源）

  • 成体干细胞
  • 胚胎组织
  • 多功能细胞

8. 人体类器官市场（依技术）

  • 3D生物列印
  • 细胞培养技术
  • 水凝胶和基于支架的技术
  • 磁浮

第九章 人体类器官市场（依应用）

  • 药物研发
  • 感染疾病监测
  • 神经学研究
  • 肿瘤监测
  • 个人化医疗
  • 再生医学

第 10 章 人体类器官市场（依最终用途）

  • 生技公司
  • 製药公司
  • 研究部门

11.美洲人类类器官市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区人类类器官市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲人类类器官市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 3Dnamics Inc.
  • AIVITA Biomedical, Inc.
  • BICO Group AB
  • Bio-Techne Corporation
  • BrainZell
  • Cannex Scientific, Inc.
  • CN Bio Innovations Limited
  • Corning Incorporated
  • DefiniGEN Limited
  • F. Hoffmann-La Roche Ltd.
  • HeartBeat.bio AG
  • Herophilus
  • HUB Organoids BV
  • InSphero AG
  • Kirkstall Ltd.
  • Merck KGaA
  • Miltenyi Biotec BV & CO. KG
  • Mimetas BV
  • Molecular Devices, LLC by Danaher Corporation
  • Neurxstem Inc.
  • Organovo Holdings Inc.
  • Pandorum Technologies Pvt. Ltd.
  • Rumi Scientific, Inc.
  • STEMCELL Technologies Canada Inc.
  • SUN bioscience SA.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • ZenBio, Inc.
Product Code: MRR-DD6333AE58DD

The Human Organoids Market was valued at USD 1.11 billion in 2024 and is projected to grow to USD 1.26 billion in 2025, with a CAGR of 15.04%, reaching USD 2.58 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.11 billion
Estimated Year [2025] USD 1.26 billion
Forecast Year [2030] USD 2.58 billion
CAGR (%) 15.04%

The development and adoption of human organoids have redefined the landscape of biomedical research and healthcare innovation. In recent years, these complex three-dimensional structures have garnered significant attention due to their ability to mimic the architecture and functionality of human organs. This emerging field is paving the way for advanced disease modeling, personalized medicine approaches, and a more nuanced understanding of cellular development. Researchers and industry leaders alike are increasingly investing in organoid technology as it offers a promising alternative to traditional in vivo and in vitro methods. By providing a more precise and replicable model of human physiology, organoids facilitate enhanced prediction of drug response and toxicity, offering the potential to streamline the drug discovery process and reduce the risks associated with clinical trials.

The current market trends reflect a surge in both academic and commercial interest, accompanied by substantial technological innovations and interdisciplinary collaboration. As new breakthroughs continue to emerge, the role and impact of organoids are set to expand even further in the realms of regenerative medicine, oncology research, and infectious disease studies. This summary provides an in-depth look into the driving forces behind this dynamic market as well as the strategic insights necessary for success in this evolving environment.

Transformative Shifts in the Human Organoids Landscape

Recent years have witnessed transformative shifts in the human organoids landscape. These shifts are characterized by rapidly evolving research methodologies, novel technological integrations, and a deeper understanding of cellular complexities that are driving the next wave of biomedical innovation. Key factors include advancements in microengineering techniques, improvements in the reproducibility of organoid cultures, and the integration of automation systems that make high-throughput screening more feasible.

Moreover, pioneering developments in imaging and data analytics have enhanced the precision with which these systems are evaluated. Emerging technologies such as real-time monitoring and advanced genetic editing have also contributed to the increased accuracy of organoid models. This integration of technology with biology is not only expanding the range of applications-from drug discovery and toxicity testing to personalized therapeutic strategies-but also enabling a more holistic approach to understanding disease mechanisms.

The sector is rapidly moving away from solely academic inquiry towards industrial applications, thereby attracting significant investments and strategic partnerships. As stakeholders actively collaborate across research institutions, biotechnology firms, and pharmaceutical companies, the convergence of these expertise areas is setting the stage for unprecedented growth and innovation in organoid technology. These industry shifts are redefining market boundaries and reshaping the traditional paradigms of biomedical research and clinical applications.

Key Segmentation Insights in the Organoid Market

The segmentation of the organoid market reveals a multifaceted landscape driven by a combination of biological, technological, and application-based factors. When examined from the perspective of type, studies have evaluated brain organoids, heart organoids, intestinal organoids, kidney organoids, liver organoids, lung organoids, and pancreatic organoids, each offering unique insights into organ-specific functions and disease modeling. The source of cells used in cultivating these organoids further adds a layer of complexity, with research and development primarily leveraging adult stem cells, embryonic tissue, and pluripotent stem cells. These foundational biological inputs are pivotal in determining the organoid's replication fidelity and functional accuracy.

Technological advancements underpinning the market include innovations in 3D bioprinting, cell culture technology, hydrogels and scaffold-based techniques, as well as magnetic levitation. Each of these technologies contributes uniquely to the overall efficiency and scalability of organoid production. Applications of organoid technology extend across drug discovery, infectious disease research, neurology studies, oncology research, personalized medicine, and regenerative medicine. These applications not only highlight the versatility of organoids but also underscore the growing dependency on these models in high-stakes research areas. Finally, the end use of organoid technology spans a wide spectrum that involves biotechnology companies, pharmaceutical companies, and research laboratories, indicating robust cross-sector interest and investment.

Integrating these segmentation insights allows stakeholders to tailor their strategies effectively, targeting specific subsections of the market while fostering innovation in areas where the demand for precise and reliable cellular models is on the rise.

Based on Type, market is studied across Brain Organoids, Heart Organoids, Intestinal Organoids, Kidney Organoids, Liver Organoids, Lung Organoids, and Pancreatic Organoids.

Based on Source, market is studied across Adult Stem Cells, Embryonic Tissue, and Pluripotent Stem Cells.

Based on Technology, market is studied across 3D Bioprinting, Cell Culture Technology, Hydrogels and Scaffold-Based Technology, and Magnetic Levitation.

Based on Application, market is studied across Drug Discovery, Infectious Disease Research, Neurology Studies, Oncology Research, Personalized Medicine, and Regenerative Medicine.

Based on End Use, market is studied across Biotechnology Companies, Pharmaceutical Companies, and Research Laboratories.

Regional Insights for the Human Organoids Market

A comprehensive analysis of the human organoids market reveals marked regional variations in both research intensity and commercial engagement. The Americas continue to lead in terms of investment and innovation, with a significant concentration of top-tier academic institutions and renowned research centers propelling advancements in organoid technology. This region benefits from substantial funding, established infrastructure, and a supportive regulatory environment that encourages both exploratory and translational research.

In Europe, the Middle East and Africa, collaborative research initiatives are fostering a growing ecosystem where academia and industry are coming together to drive innovations in organoid applications. Critical developments in regulatory standards and funding models have further boosted this region's capacity to integrate emerging technologies into mainstream biomedical research. Meanwhile, the Asia-Pacific region is rapidly evolving, buoyed by government initiatives and a burgeoning private sector that is keen to capitalize on the therapeutic and diagnostic potential of organoids. Increased investment in research infrastructure and a keen focus on technology transfer are accelerating market growth across this diverse region.

These geographical insights underscore the global momentum behind organoid technology, highlighting opportunities for strategic partnerships and market expansion across established and emerging economies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Maryland, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

In-Depth Company Insights in the Organoid Sector

The competitive landscape within the human organoids market is populated by a diverse array of companies that are pushing the boundaries of scientific discovery and technological innovation. Industry leaders such as 3Dnamics Inc. and AIVITA Biomedical, Inc. are at the forefront of next-generation organoid solutions, leveraging state-of-the-art research to drive improvements across the board. Established entities like BICO Group AB and Bio-Techne Corporation have gained recognition for their innovative approaches and robust product portfolios, while specialized firms such as BrainZell and Cannex Scientific, Inc. are rapidly emerging as key players through their focused research and development efforts.

Other notable participants include CN Bio Innovations Limited and Corning Incorporated, known for their contributions to enhancing culture conditions and providing essential laboratory equipment that support the intricate processes involved in organoid production. The likes of DefiniGEN Limited and F. Hoffmann-La Roche Ltd. have also distinguished themselves with strategic investments in research, while companies such as HeartBeat.bio AG and Herophilus are innovating at the interface of organoid technology and regenerative medicine. Further contributions by HUB Organoids B.V. and InSphero AG demonstrate that both small-scale innovators and large multinational corporations, including Kirkstall Ltd., Merck KGaA, and Miltenyi Biotec B.V. & CO. KG, are collaboratively shaping this rapidly evolving market.

Other notable contributors such as Mimetas BV, Molecular Devices, LLC by Danaher Corporation, Neurxstem Inc., and Organovo Holdings Inc. are also making significant strides with their dynamic research efforts. Companies like Pandorum Technologies Pvt. Ltd., Rumi Scientific, Inc., STEMCELL Technologies Canada Inc., SUN bioscience SA., Takara Bio Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc. round out this competitive landscape, bringing specialized expertise and innovative solutions that collectively drive the evolution of organoid applications across various biomedical fields.

The report delves into recent significant developments in the Human Organoids Market, highlighting leading vendors and their innovative profiles. These include 3Dnamics Inc., AIVITA Biomedical, Inc., BICO Group AB, Bio-Techne Corporation, BrainZell, Cannex Scientific, Inc., CN Bio Innovations Limited, Corning Incorporated, DefiniGEN Limited, F. Hoffmann-La Roche Ltd., HeartBeat.bio AG, Herophilus, HUB Organoids B.V., InSphero AG, Kirkstall Ltd., Merck KGaA, Miltenyi Biotec B.V. & CO. KG, Mimetas BV, Molecular Devices, LLC by Danaher Corporation, Neurxstem Inc., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Rumi Scientific, Inc., STEMCELL Technologies Canada Inc., SUN bioscience SA., Takara Bio Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc.. Actionable Recommendations for Industry Leaders

For industry leaders seeking to capitalize on the rapid advancements in human organoid technology, the path forward involves a robust strategy that embraces both innovation and collaboration. It is essential to invest in research and development initiatives that focus on improving the scalability and reproducibility of organoid systems. Leaders are encouraged to establish cross-disciplinary partnerships, integrating insights from cell biology, bioengineering, and data analytics to foster technological breakthroughs that will enhance the functional fidelity of organoids.

In addition, companies should explore opportunities in emerging areas such as personalized medicine and regenerative therapies. Emphasizing the integration of advanced technological tools such as 3D bioprinting, automated cell culture systems, and high-throughput screening methods can offer a competitive edge. Maintaining an agile and adaptive business model will allow organizations to swiftly pivot in response to regulatory changes and market demands. Strategic alliances with academic institutions and collaborative research centers can also help to bridge the gap between novel scientific discoveries and commercial applications.

Finally, tapping into regional strengths by customizing offerings to meet local market needs can bolster overall market presence. Investment in emerging markets, particularly in regions that are demonstrating rapid growth, will prove invaluable. Leaders who prioritize innovation, operational efficiency, and a commitment to quality are well-positioned to drive sustainable growth and achieve long-term success in this dynamic field.

Conclusion of the Human Organoids Market Analysis

In conclusion, the human organoids market is set to redefine biomedical research and therapeutic innovation. The detailed analysis presented herein underscores the multi-dimensional factors-ranging from technological advancements and strategic segmentation to regional dynamics and competitive company insights-that are collectively shaping the industry. The convergence of improved techniques, diversified application areas, and strategic investments has created a fertile environment for significant breakthroughs and sustained market growth. Stakeholders across the research and commercial spectrum are poised to benefit from the expanding applications of organoid technology, underpinned by new insights and cutting-edge innovations.

This comprehensive evaluation serves as a testament to the potential that human organoids hold in transforming clinical and research paradigms, setting the stage for future successes in drug discovery, disease modeling, and beyond. As the market continues to evolve, ongoing collaboration and agile strategy implementation remain key to unlocking the full potential of this groundbreaking technology.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Supportive government policies and funding for scientific research and tissue engineering
      • 5.1.1.2. Expanding prevalence of chronic diseases increasing the necessity for effective therapeutic research
      • 5.1.1.3. Rising demand for personalized medicine and tailored healthcare solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of research and development in human organoid technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments from biotechnology firms and venture capitalists in organoid technologies
      • 5.1.3.2. Innovative technological advancements propelling research and development in human organoids
    • 5.1.4. Challenges
      • 5.1.4.1. Ensuring ethical standards and regulatory landscape in the production and application of human organoids
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Emerging role of liver organoids in pharmacology and toxicology studies
    • 5.2.2. Innovative market segmentation analysis of human organoids for biotechnology, pharmaceuticals, and research labs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Organoids Market, by Type

  • 6.1. Introduction
  • 6.2. Brain Organoids
  • 6.3. Heart Organoids
  • 6.4. Intestinal Organoids
  • 6.5. Kidney Organoids
  • 6.6. Liver Organoids
  • 6.7. Lung Organoids
  • 6.8. Pancreatic Organoids

7. Human Organoids Market, by Source

  • 7.1. Introduction
  • 7.2. Adult Stem Cells
  • 7.3. Embryonic Tissue
  • 7.4. Pluripotent Stem Cells

8. Human Organoids Market, by Technology

  • 8.1. Introduction
  • 8.2. 3D Bioprinting
  • 8.3. Cell Culture Technology
  • 8.4. Hydrogels and Scaffold-Based Technology
  • 8.5. Magnetic Levitation

9. Human Organoids Market, by Application

  • 9.1. Introduction
  • 9.2. Drug Discovery
  • 9.3. Infectious Disease Research
  • 9.4. Neurology Studies
  • 9.5. Oncology Research
  • 9.6. Personalized Medicine
  • 9.7. Regenerative Medicine

10. Human Organoids Market, by End Use

  • 10.1. Introduction
  • 10.2. Biotechnology Companies
  • 10.3. Pharmaceutical Companies
  • 10.4. Research Laboratories

11. Americas Human Organoids Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Human Organoids Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Human Organoids Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Transforming disease research and drug discovery with Sinai Health's USD 10 million investment in lab-grown organoids
    • 14.3.2. ATCC and Tissue Dynamics Collaborate to advances cardiac safety testing in drug development
    • 14.3.3. CuSTOM and Danaher Corporation collaborate to advance drug safety with human liver organoid technology
    • 14.3.4. Revolutionary Advancements in Neurodegenerative Disease Modeling Through Stem Cell-Derived Brain Organoids
    • 14.3.5. Advancing Precision Medicine with Launch of a State-of-the-Art Organoid Facility for Next-Generation Disease Modeling
    • 14.3.6. Roche's Revolutionary Launch: The Institute of Human Biology to Propel Medical Research with Organoid Technology
    • 14.3.7. Roche Launches Institute of Human Biology in Basel to Revolutionize Drug Discovery with Organoid and Human Model System Research
    • 14.3.8. New Frontiers by National Science Foundation's Directorate for Engineering: From Organoid Intelligence to Tailored Learning
    • 14.3.9. Molecular Devices Partners with HUB Organoids to Advance 3D Biology Technologies
    • 14.3.10. Innovating Drug Discovery: Molecular Devices and HUB Organoids Forge Strategic Partnership
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3Dnamics Inc.
  • 2. AIVITA Biomedical, Inc.
  • 3. BICO Group AB
  • 4. Bio-Techne Corporation
  • 5. BrainZell
  • 6. Cannex Scientific, Inc.
  • 7. CN Bio Innovations Limited
  • 8. Corning Incorporated
  • 9. DefiniGEN Limited
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. HeartBeat.bio AG
  • 12. Herophilus
  • 13. HUB Organoids B.V.
  • 14. InSphero AG
  • 15. Kirkstall Ltd.
  • 16. Merck KGaA
  • 17. Miltenyi Biotec B.V. & CO. KG
  • 18. Mimetas BV
  • 19. Molecular Devices, LLC by Danaher Corporation
  • 20. Neurxstem Inc.
  • 21. Organovo Holdings Inc.
  • 22. Pandorum Technologies Pvt. Ltd.
  • 23. Rumi Scientific, Inc.
  • 24. STEMCELL Technologies Canada Inc.
  • 25. SUN bioscience SA.
  • 26. Takara Bio Inc.
  • 27. Thermo Fisher Scientific Inc.
  • 28. ZenBio, Inc.

LIST OF FIGURES

  • FIGURE 1. HUMAN ORGANOIDS MARKET MULTI-CURRENCY
  • FIGURE 2. HUMAN ORGANOIDS MARKET MULTI-LANGUAGE
  • FIGURE 3. HUMAN ORGANOIDS MARKET RESEARCH PROCESS
  • FIGURE 4. HUMAN ORGANOIDS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. HUMAN ORGANOIDS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HUMAN ORGANOIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN ORGANOIDS MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY BRAIN ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY HEART ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY INTESTINAL ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY KIDNEY ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY LIVER ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY LUNG ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PANCREATIC ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY EMBRYONIC TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY HYDROGELS AND SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY MAGNETIC LEVITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY INFECTIOUS DISEASE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY NEUROLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY ONCOLOGY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 244. HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 245. HUMAN ORGANOIDS MARKET, FPNV POSITIONING MATRIX, 2024